GASTROESOPHAGEAL CANCER (GC)

Clinical trials for GASTROESOPHAGEAL CANCER (GC) explained in plain language.

Never miss a new study

Get alerted when new GASTROESOPHAGEAL CANCER (GC) trials appear

Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER (GC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug combo targets genetic weakness in tough cancers

Disease control Recruiting now

This early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…

Matched conditions: GASTROESOPHAGEAL CANCER (GC)

Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

GASTROESOPHAGEAL CANCER (GC)

Get alerted when new GASTROESOPHAGEAL CANCER (GC) trials appear

New drug combo targets genetic weakness in tough cancers